Suppr
超能文献

Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.

作者信息

Breccia Massimo, Cannella Laura, Latagliata Roberto, Nanni Mauro, Santopietro Michelina, Loglisci Giuseppina, Ferretti Antonietta, Barzotti Rita, Oliva Esther N, Alimena Giuliana

出版信息

Leuk Res. 2011 Jun;35(6):e69-70. doi: 10.1016/j.leukres.2010.12.019. Epub 2011 Jan 12.

DOI:10.1016/j.leukres.2010.12.019

PMID:21232796

Abstract

摘要

相似文献

Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.

Leuk Res. 2011 Jun;35(6):e69-70. doi: 10.1016/j.leukres.2010.12.019. Epub 2011 Jan 12.

Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.

Ann Hematol. 2010 Apr;89(4):365-74. doi: 10.1007/s00277-009-0846-z. Epub 2009 Oct 24.

Myelodysplastic syndromes with del(5q): indications and strategies for cytogenetic testing.

Cancer Genet Cytogenet. 2008 Dec;187(2):101-11. doi: 10.1016/j.cancergencyto.2008.08.002.

Haematological and cytogenetic responses after only 7 days of Lenalidomide in a patient with myelodysplastic syndrome and chromosome 5q deletion.

Leuk Res. 2011 Sep;35(9):e175-6. doi: 10.1016/j.leukres.2011.05.020. Epub 2011 Jun 11.

Pleiotropic mechanisms of action of lenalidomide efficacy in del(5q) myelodysplastic syndromes.

Expert Rev Anticancer Ther. 2010 Oct;10(10):1663-72. doi: 10.1586/era.10.135.

Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional study.

Leuk Res. 2012 May;36(5):575-80. doi: 10.1016/j.leukres.2011.11.011. Epub 2011 Dec 15.

Lenalidomide--a transforming therapeutic agent in myelodysplastic syndromes.

Clin Lymphoma Myeloma. 2009;9 Suppl 3:S302-4. doi: 10.3816/CLM.2009.s.028.

Hematologic and cytogenetic response to lenalidomide monotherapy in acute myeloid leukemia arising from JAK2(V617F) positive, del(5)(q13q33) myelodysplastic syndrome.

Leukemia. 2006 Nov;20(11):2063-4. doi: 10.1038/sj.leu.2404398. Epub 2006 Sep 21.

A delayed yet durable response to very short lenalidomide therapy and unexpected clone redistribution in a case of myelodysplastic syndrome with del(5q) and del(20q).

Leuk Res. 2009 Nov;33(11):e199-202. doi: 10.1016/j.leukres.2009.06.009. Epub 2009 Jul 9.

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide.

Leukemia. 2012 Apr;26(4):855-8. doi: 10.1038/leu.2011.268. Epub 2011 Sep 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide.

作者信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

Suppr
超能文献